US Stock MarketDetailed Quotes

BMRN Biomarin Pharmaceutical

Watchlist
  • 65.810
  • -0.620-0.93%
Trading Dec 11 14:14 ET
12.54BMarket Cap39.64P/E (TTM)

Biomarin Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
63.28%221.48M
69.51%118.76M
163.53%46.97M
-9.46%159.26M
305.00%27.48M
-14.32%135.65M
24.61%70.06M
-62.73%-73.93M
-42.24%175.9M
-39.30%6.79M
Net income from continuing operations
162.72%106.08M
91.25%107.17M
74.35%88.66M
18.43%167.65M
8,282.73%20.38M
707.01%40.38M
102.57%56.04M
-57.90%50.85M
320.91%141.56M
99.57%-249K
Operating gains losses
-19.64%-2.39M
-1,189.76%-9.15M
-414.50%-20.8M
123.26%28.45M
1,185.91%22.99M
46.53%-2M
115.42%840K
105.76%6.62M
-6,656.19%-122.29M
486.18%1.79M
Depreciation and amortization
-26.00%19.01M
4.11%26.46M
3.52%27.35M
2.37%104.39M
9.40%26.86M
3.56%25.69M
0.59%25.42M
-3.37%26.42M
-5.62%101.97M
-5.51%24.55M
Deferred tax
180.99%12.17M
0.00%1.25M
104.48%285K
13.64%-44.98M
51.61%-24.84M
-258.00%-15.03M
193.09%1.25M
-232.50%-6.36M
-233.72%-52.09M
-1,330.99%-51.34M
Other non cash items
-41.98%322K
-99.63%6K
38.41%1.12M
1.19%3.82M
199.41%849K
-55.60%555K
574.12%1.61M
-78.32%807K
-60.41%3.78M
-157.24%-854K
Change In working capital
-2.15%39.06M
-6.73%-66.92M
51.35%-105.39M
-249.17%-336.54M
-638.86%-97.12M
-56.39%39.92M
-64.68%-62.7M
-58.49%-216.64M
-245.96%-96.38M
-11,231.03%-13.14M
-Change in receivables
-635.42%-74.38M
-649.04%-52.7M
97.56%-3.39M
-132.14%-190.44M
-106.83%-58.5M
-64.21%13.89M
81.36%-7.04M
-153.22%-138.8M
-225.10%-82.03M
-46,462.30%-28.28M
-Change in inventory
143.76%18.15M
27.82%-30.59M
-19.31%-16.82M
-130.07%-157.06M
-44.72%-59.11M
-59.58%-41.47M
-1,557.98%-42.38M
-1,353.16%-14.1M
-94.71%-68.26M
-156.32%-40.85M
-Change in payables and accrued expense
50.17%122.28M
-28.03%4.75M
-86.22%-59.01M
16.66%68.85M
-79.61%12.52M
10.11%81.43M
266.69%6.59M
59.45%-31.69M
276.17%59.02M
169.16%61.42M
-Change in other current assets
-44.24%-30.51M
136.17%8.22M
18.83%-29.48M
-576.95%-81.48M
91.79%-1.28M
-428.80%-21.16M
-710.97%-22.72M
-452.79%-36.32M
-151.96%-12.04M
-352.07%-15.62M
-Change in other current liabilities
-51.31%3.52M
19.63%3.4M
-22.36%3.31M
240.18%23.59M
-9.16%9.25M
531.32%7.23M
186.49%2.84M
149.24%4.26M
307.82%6.93M
382.52%10.19M
Cash from discontinued investing activities
Operating cash flow
63.28%221.48M
69.51%118.76M
163.53%46.97M
-9.46%159.26M
305.00%27.48M
-14.32%135.65M
24.61%70.06M
-62.73%-73.93M
-42.24%175.9M
-39.30%6.79M
Investing cash flow
Cash flow from continuing investing activities
64.72%-16.16M
206.40%90.48M
52.57%-14.24M
-455.41%-111.24M
-18.74%-64.96M
-95.71%-45.8M
199.43%29.53M
-134.19%-30.01M
94.53%-20.03M
1.28%-54.71M
Net PPE purchase and sale
15.05%-18.46M
1.19%-21.33M
-6.74%-26.1M
20.06%-96.69M
18.97%-28.92M
25.82%-21.74M
20.52%-21.58M
15.13%-24.46M
-26.56%-120.96M
-24.18%-35.69M
Net intangibles purchase and sale
-61.10%-2.71M
55.36%-512K
-2,480.65%-8M
-3.20%-10.92M
-1,059.31%-7.78M
76.52%-1.68M
-30.19%-1.15M
83.32%-310K
55.25%-10.58M
95.70%-671K
Net investment purchase and sale
117.33%3.88M
114.92%112.32M
288.11%9.87M
-144.38%-3.63M
-142.09%-28.27M
-271.24%-22.38M
3,240.63%52.26M
-162.03%-5.25M
103.33%8.19M
-5.55%-11.68M
Net other investing changes
--1.14M
--0
--10M
----
----
----
----
----
10,494.87%103.33M
---6.68M
Cash from discontinued investing activities
Investing cash flow
64.72%-16.16M
206.40%90.48M
52.57%-14.24M
-455.41%-111.24M
-18.74%-64.96M
-95.71%-45.8M
199.43%29.53M
-134.19%-30.01M
94.53%-20.03M
1.28%-54.71M
Financing cash flow
Cash flow from continuing financing activities
-63,240.74%-499.13M
5.43%12.61M
-5.03%-42.79M
-0.41%-18.73M
-0.27%10.84M
-110.45%-788K
201.55%11.96M
-61.16%-40.74M
-38,754.17%-18.65M
-24.50%10.87M
Net issuance payments of debt
-30,370.76%-494.93M
97.10%-18K
95.86%-42K
12.25%-2.29M
-135.67%-2.29M
418.71%1.64M
-11.69%-621K
-79.15%-1.01M
14.28%-2.61M
-77.33%-970K
Proceeds from stock option exercised by employees
10.15%4.8M
1.37%29.42M
-66.00%7.2M
0.03%69.35M
-41.87%14.81M
-69.70%4.36M
36.53%29.02M
157.06%21.17M
40.94%69.33M
56.08%25.47M
Net other financing activities
-32.71%-9M
-2.14%-16.79M
17.98%-49.95M
-0.49%-85.79M
87.68%-1.68M
-7.26%-6.78M
49.39%-16.44M
-84.82%-60.9M
-84.79%-85.38M
-891.85%-13.63M
Cash from discontinued financing activities
Financing cash flow
-63,240.74%-499.13M
5.43%12.61M
-5.03%-42.79M
-0.41%-18.73M
-0.27%10.84M
-110.45%-788K
201.55%11.96M
-61.16%-40.74M
-38,754.17%-18.65M
-24.50%10.87M
Net cash flow
Beginning cash position
40.00%972.15M
28.78%747M
4.22%755.13M
23.37%724.53M
3.14%785.41M
12.03%694.38M
-4.19%580.07M
23.37%724.53M
-9.53%587.28M
23.39%761.52M
Current changes in cash
-429.89%-293.8M
98.87%221.85M
93.05%-10.06M
-78.66%29.29M
28.11%-26.64M
-37.48%89.06M
656.46%111.56M
-947.55%-144.69M
321.95%137.22M
-24.16%-37.06M
Effect of exchange rate changes
-246.96%-2.9M
19.91%3.3M
741.48%1.93M
3,987.50%1.31M
-5,236.62%-3.65M
364.26%1.97M
814.81%2.75M
-79.05%229K
156.14%32K
422.73%71K
End cash Position
-14.00%675.45M
40.00%972.15M
28.78%747M
4.22%755.13M
4.22%755.13M
3.14%785.41M
12.03%694.38M
-4.19%580.07M
23.37%724.53M
23.37%724.53M
Free cash flow
78.48%200.31M
104.77%96.92M
113.04%12.87M
16.42%51.65M
68.85%-9.21M
-7.90%112.23M
67.90%47.33M
-29.68%-98.7M
-76.06%44.36M
10.87%-29.57M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 63.28%221.48M69.51%118.76M163.53%46.97M-9.46%159.26M305.00%27.48M-14.32%135.65M24.61%70.06M-62.73%-73.93M-42.24%175.9M-39.30%6.79M
Net income from continuing operations 162.72%106.08M91.25%107.17M74.35%88.66M18.43%167.65M8,282.73%20.38M707.01%40.38M102.57%56.04M-57.90%50.85M320.91%141.56M99.57%-249K
Operating gains losses -19.64%-2.39M-1,189.76%-9.15M-414.50%-20.8M123.26%28.45M1,185.91%22.99M46.53%-2M115.42%840K105.76%6.62M-6,656.19%-122.29M486.18%1.79M
Depreciation and amortization -26.00%19.01M4.11%26.46M3.52%27.35M2.37%104.39M9.40%26.86M3.56%25.69M0.59%25.42M-3.37%26.42M-5.62%101.97M-5.51%24.55M
Deferred tax 180.99%12.17M0.00%1.25M104.48%285K13.64%-44.98M51.61%-24.84M-258.00%-15.03M193.09%1.25M-232.50%-6.36M-233.72%-52.09M-1,330.99%-51.34M
Other non cash items -41.98%322K-99.63%6K38.41%1.12M1.19%3.82M199.41%849K-55.60%555K574.12%1.61M-78.32%807K-60.41%3.78M-157.24%-854K
Change In working capital -2.15%39.06M-6.73%-66.92M51.35%-105.39M-249.17%-336.54M-638.86%-97.12M-56.39%39.92M-64.68%-62.7M-58.49%-216.64M-245.96%-96.38M-11,231.03%-13.14M
-Change in receivables -635.42%-74.38M-649.04%-52.7M97.56%-3.39M-132.14%-190.44M-106.83%-58.5M-64.21%13.89M81.36%-7.04M-153.22%-138.8M-225.10%-82.03M-46,462.30%-28.28M
-Change in inventory 143.76%18.15M27.82%-30.59M-19.31%-16.82M-130.07%-157.06M-44.72%-59.11M-59.58%-41.47M-1,557.98%-42.38M-1,353.16%-14.1M-94.71%-68.26M-156.32%-40.85M
-Change in payables and accrued expense 50.17%122.28M-28.03%4.75M-86.22%-59.01M16.66%68.85M-79.61%12.52M10.11%81.43M266.69%6.59M59.45%-31.69M276.17%59.02M169.16%61.42M
-Change in other current assets -44.24%-30.51M136.17%8.22M18.83%-29.48M-576.95%-81.48M91.79%-1.28M-428.80%-21.16M-710.97%-22.72M-452.79%-36.32M-151.96%-12.04M-352.07%-15.62M
-Change in other current liabilities -51.31%3.52M19.63%3.4M-22.36%3.31M240.18%23.59M-9.16%9.25M531.32%7.23M186.49%2.84M149.24%4.26M307.82%6.93M382.52%10.19M
Cash from discontinued investing activities
Operating cash flow 63.28%221.48M69.51%118.76M163.53%46.97M-9.46%159.26M305.00%27.48M-14.32%135.65M24.61%70.06M-62.73%-73.93M-42.24%175.9M-39.30%6.79M
Investing cash flow
Cash flow from continuing investing activities 64.72%-16.16M206.40%90.48M52.57%-14.24M-455.41%-111.24M-18.74%-64.96M-95.71%-45.8M199.43%29.53M-134.19%-30.01M94.53%-20.03M1.28%-54.71M
Net PPE purchase and sale 15.05%-18.46M1.19%-21.33M-6.74%-26.1M20.06%-96.69M18.97%-28.92M25.82%-21.74M20.52%-21.58M15.13%-24.46M-26.56%-120.96M-24.18%-35.69M
Net intangibles purchase and sale -61.10%-2.71M55.36%-512K-2,480.65%-8M-3.20%-10.92M-1,059.31%-7.78M76.52%-1.68M-30.19%-1.15M83.32%-310K55.25%-10.58M95.70%-671K
Net investment purchase and sale 117.33%3.88M114.92%112.32M288.11%9.87M-144.38%-3.63M-142.09%-28.27M-271.24%-22.38M3,240.63%52.26M-162.03%-5.25M103.33%8.19M-5.55%-11.68M
Net other investing changes --1.14M--0--10M--------------------10,494.87%103.33M---6.68M
Cash from discontinued investing activities
Investing cash flow 64.72%-16.16M206.40%90.48M52.57%-14.24M-455.41%-111.24M-18.74%-64.96M-95.71%-45.8M199.43%29.53M-134.19%-30.01M94.53%-20.03M1.28%-54.71M
Financing cash flow
Cash flow from continuing financing activities -63,240.74%-499.13M5.43%12.61M-5.03%-42.79M-0.41%-18.73M-0.27%10.84M-110.45%-788K201.55%11.96M-61.16%-40.74M-38,754.17%-18.65M-24.50%10.87M
Net issuance payments of debt -30,370.76%-494.93M97.10%-18K95.86%-42K12.25%-2.29M-135.67%-2.29M418.71%1.64M-11.69%-621K-79.15%-1.01M14.28%-2.61M-77.33%-970K
Proceeds from stock option exercised by employees 10.15%4.8M1.37%29.42M-66.00%7.2M0.03%69.35M-41.87%14.81M-69.70%4.36M36.53%29.02M157.06%21.17M40.94%69.33M56.08%25.47M
Net other financing activities -32.71%-9M-2.14%-16.79M17.98%-49.95M-0.49%-85.79M87.68%-1.68M-7.26%-6.78M49.39%-16.44M-84.82%-60.9M-84.79%-85.38M-891.85%-13.63M
Cash from discontinued financing activities
Financing cash flow -63,240.74%-499.13M5.43%12.61M-5.03%-42.79M-0.41%-18.73M-0.27%10.84M-110.45%-788K201.55%11.96M-61.16%-40.74M-38,754.17%-18.65M-24.50%10.87M
Net cash flow
Beginning cash position 40.00%972.15M28.78%747M4.22%755.13M23.37%724.53M3.14%785.41M12.03%694.38M-4.19%580.07M23.37%724.53M-9.53%587.28M23.39%761.52M
Current changes in cash -429.89%-293.8M98.87%221.85M93.05%-10.06M-78.66%29.29M28.11%-26.64M-37.48%89.06M656.46%111.56M-947.55%-144.69M321.95%137.22M-24.16%-37.06M
Effect of exchange rate changes -246.96%-2.9M19.91%3.3M741.48%1.93M3,987.50%1.31M-5,236.62%-3.65M364.26%1.97M814.81%2.75M-79.05%229K156.14%32K422.73%71K
End cash Position -14.00%675.45M40.00%972.15M28.78%747M4.22%755.13M4.22%755.13M3.14%785.41M12.03%694.38M-4.19%580.07M23.37%724.53M23.37%724.53M
Free cash flow 78.48%200.31M104.77%96.92M113.04%12.87M16.42%51.65M68.85%-9.21M-7.90%112.23M67.90%47.33M-29.68%-98.7M-76.06%44.36M10.87%-29.57M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Heat List
US
Overall
Symbol
Price
% Chg

No Data